Clinical trial
DP-R212 Pharmacokinetic Study
NCT02789475 is registered in ClinicalTrials.gov with Alvogen Korea as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- DP-R212 Pharmacokinetic Study
- Lead sponsor
- Alvogen Korea
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- May 31, 2016
- Completion date
- July 31, 2016
- Enrollment
- 38 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.